Axinn partner Chad Landmon talked with Bloomberg Law TV to discuss FDA medical device approval under the new administration. During the extensive video, Chad discusses the recent regulatory changes, what they mean for the industry and consumers, and what to expect from the FDA in 2018.

Click here to access the video interview and article.